Ligand-size and ligand-chain hydrophilicity effects on the relaxometric properties of ultrasmall Gd2O3 nanoparticles
Source abstract
Abstract
The relaxometric properties of ultrasmall Gd2O3 nanoparticles coated with various ligands were investigated. These ligands include small diacids with hydrophobic chains, namely, succinic acid (Mw = 118.09 amu), glutaric acid (Mw = 132.12 amu), and terephthalic acid (Mw = 166.13 amu), and large polyethylenimines (PEIs) with hydrophilic chains, namely, PEI-1300 (M¯n=1300) and PEI-10000 (M¯n=10000). Ligand-size and ligand-chain hydrophilicity effects were observed. The longitudinal (r1) and transverse (r2) water proton relaxivities generally decreased with increasing ligand-size (the ligand-size effect). The ligand-size effect was weaker for PEI because its hydrophilic chains allow water molecules to access the nanoparticle (the ligand-chain hydrophilicity effect). This result was explained on the basis of the magnetic dipole interaction between the dipoles of the nanoparticle and water proton. In addition, all samples were found to be non-toxic in cellular cytotoxicity tests.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Lanthanide and Transition Metal Complexes · Magnetism in coordination complexes · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Kyungpook National University (KNU) 1 Department of Chemistry and Department of Nanoscience and Nanotechnology (DNN), College of Natural Sciences, , Taegu 41566, South Korea
Teacher’s College 2 Department of Biology Education and DNN, , KNU, Taegu 41566, South Korea
School of Medicine and Hospital 3 Department of Molecular Medicine and Medical & Biological Engineering and DNN, , KNU, Taegu 41566, South Korea
Funding
National Research Foundation of Korea
References (38)
Show source-provided references
1. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging10.1021/ja068356j ↗
2. High proton relaxivity for gadolinium oxide nanoparticles10.1007/s10334-006-0039-x ↗
3. Polyethylene glycol-covered ultra-small Gd2O3 nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning10.1088/0957-4484/18/39/395501 ↗
4. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement10.1021/la903566y ↗
5. Synthesis of ultrafine Gd2O3 nanoparticles inside single-wall carbon nanohorns10.1021/jp0607622 ↗
6. Synthesis and characterization of Tb3+-doped Gd2O3 nanocrystals: a bifunctional material with combined fluorescent labeling and MRI contrast agent properties10.1021/jp808708m ↗
7. Gd2O(CO3)2.H2O particles and the corresponding Gd2O3: synthesis and applications of magnetic resonance contrast agents and template particles for hollow spheres and hybrid composites10.1002/adfm.200700702 ↗
8. Gadolinium-based hybrid nanoparticles as a positive MR contrast agent10.1021/ja066442d ↗
9. Surface modification of gadolinium oxide thin films and nanoparticles using poly(ethylene glycol)-phosphate10.1021/la202780x ↗
10. Size-tunable, ultrasmall NaGdF4 nanoparticles: insight into their T1 MRI contrast enhancement10.1021/cm201297x ↗
11. Synthesis of Gd doped CdSe nanoparticles for potential optical and MR imaging applications10.1039/b924089f ↗
12. Water-soluble GdF3 and GdF3/LaF3 nanoparticles-physical characterization and NMR relaxation properties10.1021/cm052299w ↗
13. Nanoscale metal-organic frameworks as potential multimodal contrast enhancing agents10.1021/ja0627444 ↗
14. Blood-pool and targeting MRI contrast agents: from Gd-chelates to Gd-nanoparticles10.1002/ejic.201101137 ↗
15. Paramagnetic nanoparticle T1 and T2 MRI contrast agents10.1039/c2cp41357d ↗
16. Gadolinium oxide nanoparticles as potential multimodal imaging and therapeutic agents10.2174/1568026611313040003 ↗
17. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images10.1021/nn900761s ↗
18. Physico-chemical and NMR relaxometric characterization of gadolinium hydroxide and dysprosium oxide nanoparticles10.1088/0957-4484/19/47/475102 ↗
19. Tuning of the size of Dy2O3 nanoparticles for optimal performance as an MRI contrast agent10.1021/ja711492y ↗
20. Ligand-size dependent water proton relaxivities in ultrasmall gadolinium oxide nanoparticles and in vivo T1 MR images in a 1.5 T MR field10.1039/C4CP01946F ↗
21. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design10.1021/cr00081a003 ↗
22. A facile synthesis, in vitro and in vivo MR studies of D-glucuronic acid-coated ultrasmall Ln2O3 (Ln = Eu, Gd, Dy, Ho, and Er) nanoparticles as a new potential MRI contrast agent10.1021/am200437r ↗
23. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications10.1021/cr980440x ↗
24. Theory of proton relaxation induced by superparamagnetic particles10.1063/1.478435 ↗
25. NMR transversal relaxivity of suspensions of lanthanide oxide nanoparticles10.1021/jp072288l ↗
26. 1972
27. Synthesis and characterization of Gd2O3 nanocrystals functionalized by organic acids10.1016/j.jcis.2005.02.089 ↗
28. 1997
29. Surface complexation and dissolution of hematite by C1-C6 dicarboxylic acids at pH = 5.010.1016/S0016-7037(01)00696-2 ↗
30. Infrared spectra of oxalate, malonate and succinate adsorbed on the aqueous surface of rutile, anatase and lepidocrocite measured with in situ ATR-FTIR10.1016/j.elspec.2005.05.006 ↗
31. In situ fourier transform infrared spectroscopic evidence for the formation of several different surface complexes of oxalate on TiO2 in the aqueous phase10.1021/la00022a036 ↗
32. ATR-FTIR measurements and quantum chemical calculations concerning the adsorption and photoreaction of oxalic acid on TiO210.1039/b518007b ↗
33. Fluorescein-polyethyleneimine coated gadolinium oxide nanoparticles as T1 magnetic resonance imaging (MRI)-cell labeling (CL) dual agents10.1039/c2ra21052e ↗
34. Hard and soft acids and bases10.1021/ja00905a001 ↗
35. Hard and soft acids and bases, HSAB, part 1: fundamental principles10.1021/ed045p581 ↗
36. Hard and soft acids and bases, HSAB, part II: underlying theories10.1021/ed045p643 ↗
37. Polymer-stabilized gold nanoparticles with high grafting densities10.1021/la0355702 ↗
38. Manipulating the surface coating of ultra-small Gd2O3 nanoparticles for improved T1-weighted MR imaging10.1016/j.biomaterials.2013.11.032 ↗